Peer Review reports
From: Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
| Original Submission | ||
|---|---|---|
| 2 Nov 2020 | Submitted | Original manuscript |
| 26 Nov 2020 | Reviewed | Reviewer Report |
| 10 Jan 2021 | Reviewed | Reviewer Report |
| 10 Feb 2021 | Author responded | Author comments - Natasha F Sabur |
| Resubmission - Version 2 | ||
| 10 Feb 2021 | Submitted | Manuscript version 2 |
| 11 Feb 2021 | Reviewed | Reviewer Report |
| 27 Feb 2021 | Author responded | Author comments - Natasha F Sabur |
| Resubmission - Version 3 | ||
| 27 Feb 2021 | Submitted | Manuscript version 3 |
| Publishing | ||
| 2 Mar 2021 | Editorially accepted | |
| 10 Mar 2021 | Article published | 10.1186/s12879-021-05947-6 |
You can find further information about peer review here.